UPDATE : Tuesday, November 20, 2018
EU grants 1st approval for Siemens' new MRI scanner
  • By Marian Chu
  • Published 2017.09.07 16:38
  • Updated 2017.09.07 16:38
  • comments 0

Siemens Healthcare Korea said Thursday that Siemens Healthineers won the first European regulatory approval for an ultra-high field magnetic resonance imaging (MRI) scanner called Magnetom Terra.

Siemens' MAGNETOM Terra

European medical practitioners will be able to use Magnetom Terra in routine clinical settings for neurological and musculoskeletal examinations with the CE certification.

The EU regulatory body’s stamp of approval indicates the device meets all requirements regarding stability, clinical benefit and environmental protection in radiology, the company said.

“Magnetom Terra's CE certification is the first of its kind in 15 years since the 3-Tesla MR devices,” said Christoph Zindel, senior vice-president and general manager of Siemens Healthineers MRI division. “We are confident that Magnetom Terra will help open up new horizons in MRI medical research and clinical practice.”

The scanner is an ultra-high field MR system with a magnetic field strength of 7-Tesla, which is impressively stronger than the current high-end standard 3-Tesla. The scanner was used mainly by researchers to see the brain in minute detail, identifying components in the brain as small as a grain of sand.

Magnetom Terra’s excellent spatial and spectral resolution will help medical practitioners examine the human musculoskeletal system in detail and precisely photograph brain metabolism process, the company said.

The device can also visually confirm neurological diseases such as Alzheimer’s, brain metastasis, and multiple sclerosis, it said. In particular, it can identify lesions more clearly such as better white and gray matter differentiation in epilepsy and improved visibility in gray matter for multiple sclerosis.

“We have been able to realize 7-Tesla MR imaging in a clinical setting as a result of many years of collaborative research in the field of ultrasound MRIs with a broad network of research collaboration partners around the world,” Zindel added.

The device is pending on U.S. FDA approval and is in the pre-approval stage in Korea.


<© Korea Biomedical Review, All rights reserved.>

Other articles by Marian Chu
iconMost viewed
Comments 0
Please leave the first comment.
Back to Top